Skip to main content

Table 3 Cytotoxicity of L-OHP on OCUM-2MD3/L-OHP (μg/mL, %, x ¯ ± S, 24 h).

From: Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro

Group 600 300 150 75 37.5 IC50
OCUM-2MD3 76.2 ± 1.1 69.3 ± 2.3 57.7 ± 1.3 44.2 ± 0.9 28.3 ± 2.6 111.3
OCUM-2MD3/L-OHP 60.6 ± 0.5* 42.6 ± 1.3* 35.5 ± 4.2* 19.9 ± 1.7* 6.4 ± 2.1* 354.4
  1. *Compared with OCUM-2MD3 Group P < 0.05